Literature DB >> 16678816

The AP-1 transcription factor regulates postnatal mammary gland development.

Qiang Shen1, Yun Zhang, Ivan P Uray, Jamal L Hill, Hee-Tae Kim, Chunhua Lu, Matthew R Young, Edward J Gunther, Susan G Hilsenbeck, Lewis A Chodosh, Nancy H Colburn, Powel H Brown.   

Abstract

The AP-1 transcription factor is activated by multiple growth factors that are critical regulators of breast cell proliferation. We previously demonstrated that AP-1 blockade inhibits breast cancer cell growth in vitro. Yet a specific role of AP-1 in normal mammary gland development has not been studied. Using a bi-transgenic mouse expressing an inducible AP-1 inhibitor (Tam67), we found that the AP-1 factor regulates postnatal proliferation of mammary epithelial cells. Mammary epithelial proliferation was significantly reduced after AP-1 blockade in adult, prepubertal, pubertal, and hormone-stimulated mammary glands. In pubertal mice, mammary cell proliferation was greatly reduced, and the cells that did proliferate failed to express Tam67. We also observed structural changes such as suppressed branching and budding, reduced gland tree size, and less fat pad occupancy in developing mammary glands after AP-1 blockade. We further demonstrated that Tam67 suppressed the expression of AP-1-dependent genes (TIMP-1, vimentin, Fra-1, and fibronectin) and the AP-1-dependent growth regulatory genes (cyclin D1 and c-myc) in AP-1-blocked mammary glands. We therefore conclude that AP-1 factor is a pivotal regulator of postnatal mammary gland growth and development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16678816     DOI: 10.1016/j.ydbio.2006.03.042

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  21 in total

Review 1.  Mammary gland involution as a multi-step process.

Authors:  Torsten Stein; Nathan Salomonis; Barry A Gusterson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-03       Impact factor: 2.673

2.  Conditional knockout of fibronectin abrogates mouse mammary gland lobuloalveolar differentiation.

Authors:  Keyi Liu; Le Cheng; Andrea Flesken-Nikitin; Lynn Huang; Alexander Y Nikitin; Bendicht U Pauli
Journal:  Dev Biol       Date:  2010-08-10       Impact factor: 3.582

3.  C/EBPβ LIP and c-Jun synergize to regulate expression of the murine progesterone receptor.

Authors:  Weizhong Wang; Han Ngoc Do; Mark D Aupperlee; Srinivasan Durairaj; Emily E Flynn; Richard J Miksicek; Sandra Z Haslam; Richard C Schwartz
Journal:  Mol Cell Endocrinol       Date:  2018-06-02       Impact factor: 4.102

4.  Prolactin-growth factor crosstalk reduces mammary estrogen responsiveness despite elevated ERalpha expression.

Authors:  Lisa M Arendt; Tara L Grafwallner-Huseth; Linda A Schuler
Journal:  Am J Pathol       Date:  2009-01-29       Impact factor: 4.307

Review 5.  Steroid hormone receptors as prognostic markers in breast cancer.

Authors:  Maggie C Louie; Mary B Sevigny
Journal:  Am J Cancer Res       Date:  2017-08-01       Impact factor: 6.166

6.  Effect of lapatinib on the development of estrogen receptor-negative mammary tumors in mice.

Authors:  Tracy E Strecker; Qiang Shen; Yun Zhang; Jamal L Hill; Yuxin Li; Chunyu Wang; Hee-Tae Kim; Tona M Gilmer; Krystal R Sexton; Susan G Hilsenbeck; C Kent Osborne; Powel H Brown
Journal:  J Natl Cancer Inst       Date:  2009-01-13       Impact factor: 13.506

7.  Jnk2 effects on tumor development, genetic instability and replicative stress in an oncogene-driven mouse mammary tumor model.

Authors:  Peila Chen; Jamye F O'Neal; Nancy D Ebelt; Michael A Cantrell; Shreya Mitra; Azadeh Nasrazadani; Tracy L Vandenbroek; Lynn E Heasley; Carla L Van Den Berg
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

8.  Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy.

Authors:  Mahasweta Girgenrath; Mary Lou Beermann; Vivek K Vishnudas; Sachiko Homma; Jeffrey Boone Miller
Journal:  Ann Neurol       Date:  2009-01       Impact factor: 10.422

9.  Prolactin cooperates with loss of p53 to promote claudin-low mammary carcinomas.

Authors:  K A O'Leary; D E Rugowski; R Sullivan; L A Schuler
Journal:  Oncogene       Date:  2013-07-22       Impact factor: 9.867

10.  ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex.

Authors:  Zhe Li; Cristina E Tognon; Frank J Godinho; Laura Yasaitis; Hanno Hock; Jason I Herschkowitz; Chris L Lannon; Eunah Cho; Seong-Jin Kim; Roderick T Bronson; Charles M Perou; Poul H Sorensen; Stuart H Orkin
Journal:  Cancer Cell       Date:  2007-12       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.